Navigation Links
VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7
Date:1/21/2008

SAN JOSE, Calif., Jan. 21 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the fourth quarter ended December 31, 2007, after the close of market on February 7.

VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PT / 5:00 p.m. ET on February 7. This call will be webcast live for all investors and archived on the company's website at http://www.vnus.com.

How to Access the Teleconference Webcast

VNUS Medical Technologies Fourth-Quarter 2007 Teleconference

Thursday, February 7

2:00 p.m. PT / 5:00 p.m. ET

Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly. In addition to the webcast replay, a phone replay will be available for seven days after the live call at (719) 457-0820, code number 6554815.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been tre
'/>"/>

SOURCE VNUS Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEt... "Company"), a global biopharmaceutical company fo...ounced that the U.S. Food and Drug Administration ...ompany,s PI3K/Akt pathway inhibitor compound, peri...efractory multiple myeloma. Keryx Biopharmaceutica...
(Date:12/2/2009)... The Scientist, a leading scientifi...ometrics’ Evolve “Intelligent” E...ldquo;Top 10 Innovations of 2009. , ... ™ EMCCD camera from Photometrics ®, a... and EMCCD cameras for the life sciences, was rank...
(Date:12/1/2009)... Dr. Kerry Solomon announced that h...aunched his redesigned website at www.DrKerrySolo...g Group. Dr. Solomon is a proven LASIK, lens impl...essionally recognized for his substantial contribu...is a member of Trusted LASIK Surgeons, which scree...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlin...t is available in its catalogue: ,, Chromium ...inker.com/p0164494/Chromium---Global-Market-Trends...arily influenced by stainless steel, while growth ... also important for growth of chromium metal. Envi...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...ass., Feb. 3 Abt Associates announced that Ricky ...Associate. After a brief orientation to the firm,... education work in September 2009. Dr. Takai brin... and management of federal evaluation studies in t...cently, Dr. Takai served as Associate Commissioner...
...b. 3 AngioGenex Inc. (OTC Bulletin Board: AGGX.OB...s pioneering the targeting of Id genes and protein...enic drugs to treat cancer. Today the Company anno...t scientific meetings that demonstrate the ability...o mitigate tumor formation and metastases. , , Dr...
.... 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nas...pecializing in the development of innovative thera... announced that Robert Kirkman, M.D., President an...h Annual BIO CEO & Investor Conference in New ...bruary 9, 2009. , A live and archived webcast of D...
Other Biology Technology:Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates 2AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences 2AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences 3
(Date:12/3/2009)... Coral reef fish can undergo a personality change...tudy suggesting that climate change may make some ...species of young damselfish on Australia,s Great B...e reef fish are either consistently timid, or cons...es are even more marked as water temperatures rise...
(Date:12/3/2009)... Forest dwellers must be included in the design o...to avoid a humanitarian crisis, according to a sci...day in Nature , Dr Simon Lewis argues that at lea...at Copenhagen, known as REDD (Reducing Emissions f... to forest dwellers directly, and their property r...
(Date:12/3/2009)... The UK leads the world when it comes to investme...Engineering and Physical Sciences Research Council...more is needed: "Scientific and engineering resear... and solar power solutions, but more investment is...olutions if we are to meet our carbon emission tar...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Research is vital to a cleaner, greener, low carbon future 2Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology 50348 1Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology 50348 2Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology 50348 3AUDIO from Medialink and AARP 3A Helping Older Americans Buy Groceries in a Snap 50343 1BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 1BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 2BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 3BioMed Realty Trust Completes 24350 Million Financing for Center for Life Science Boston 50338 4
...y of Florida-led study has determined that Titanis...rror bird," arrived in North America from South Am...continents. , UF paleontologist Bruce MacFadden sa...que that analyzes rare earth elements in a new app... in Texas and Florida, the only places in North Am...
...d researchers tapping the massive flow of DNA sequ...their recent developments at the 2nd Annual U.S. D...I) User Meeting. DOE JGI is the world,s only user ...equencing available to a diverse research communit... not have access to such a resource to advance the...
...ogy, the size of a mobile phone, which could save ... scientists from The University of Nottingham. The...ential danger. It is small and easy to use so that...baby’s heart beat without having to go into hospit...gy allows them to do this. , It took 15 years of p...
Other Biology News:'Terror bird' arrived in North America before land bridge, study finds 2A revolution in the monitoring of unborn babies 2A revolution in the monitoring of unborn babies 3
Mouse Serum from Innovative Research
Varian 4000 Ion Trap GC/MS from Varian, Inc.
GeneRacer Kit with AMV RT and TOPO TA Cloning kit for Sequencing from Invitrogen
...esenilin 2 Alzheimer's disease (AD) patients with...in the presenilin proteins (PSEN1; PSEN2) or the a...ed mutations result in increased production of the...yloid deposits found in AD brains). Presenilins ar...
Biology Products: